Stephanie Greene - Airsculpt Technologies Chief Officer
| AIRS Stock | USD 4.85 0.09 1.89% |
Executive
Stephanie Greene is Chief Officer of Airsculpt Technologies
| Address | 1111 Lincoln Road, Miami Beach, FL, United States, 33139 |
| Phone | 786 709 9690 |
| Web | https://elitebodysculpture.com |
Airsculpt Technologies Management Efficiency
The company has return on total asset (ROA) of 0.0112 % which means that it generated a profit of $0.0112 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0935) %, meaning that it created substantial loss on money invested by shareholders. Airsculpt Technologies' management efficiency ratios could be used to measure how well Airsculpt Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.07 in 2025. Return On Capital Employed is likely to drop to 0.03 in 2025. At this time, Airsculpt Technologies' Net Tangible Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 6.8 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 192.8 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Elissa Charbonneau | Encompass Health Corp | 64 | |
| Christine Bent | InnovAge Holding Corp | 54 | |
| Geraldine Geckle | Universal Health Services | N/A | |
| Laura Szitar | Oncology Institute | N/A | |
| FACS MD | Oncology Institute | 52 | |
| Bill Priest | Acadia Healthcare | N/A | |
| Jason Steik | Pennant Group | N/A | |
| Gretchen Hommrich | Acadia Healthcare | N/A | |
| Monica Raines | Addus HomeCare | 45 | |
| Varun Gadhok | Surgery Partners | N/A | |
| Marissa Brittenham | Surgery Partners | 40 | |
| Ryan Solomon | Enhabit | N/A | |
| Scott Ginn | Amedisys | 55 | |
| Brian Monahan | Addus HomeCare | N/A | |
| Dustin Lee | InnovAge Holding Corp | N/A | |
| Shannon Drake | Aveanna Healthcare Holdings | 48 | |
| Jordan McInerney | Oncology Institute | N/A | |
| Mark Esq | Oncology Institute | N/A | |
| Debbie Stewart | Aveanna Healthcare Holdings | N/A | |
| Kirk Cheney | Pennant Group | N/A | |
| Danielle Burkhalter | Surgery Partners | 39 | |
Management Performance
| Return On Equity | -0.0935 | ||||
| Return On Asset | 0.0112 |
Airsculpt Technologies Leadership Team
Elected by the shareholders, the Airsculpt Technologies' board of directors comprises two types of representatives: Airsculpt Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Airsculpt. The board's role is to monitor Airsculpt Technologies' management team and ensure that shareholders' interests are well served. Airsculpt Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Airsculpt Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dennis Dean, Chief Officer | ||
| Stephanie Greene, Chief Officer | ||
| Philip Bodie, Chief Officer | ||
| Aaron MD, Founder Chairman | ||
| Liraz Isaac, Head People | ||
| Todd Magazine, President CEO | ||
| Dennis CPA, Chief Officer | ||
| Ronald Zelhof, COO Pres | ||
| Yogesh Jashnani, CEO Director |
Airsculpt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Airsculpt Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0935 | ||||
| Return On Asset | 0.0112 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 371.74 M | ||||
| Shares Outstanding | 57.88 M | ||||
| Shares Owned By Insiders | 26.90 % | ||||
| Shares Owned By Institutions | 73.25 % | ||||
| Number Of Shares Shorted | 2.95 M | ||||
| Price To Earning | 143.17 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Airsculpt Stock Analysis
When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.